249 related articles for article (PubMed ID: 18371145)
1. Diagnostic accuracy of serum hyaluronic acid, FIBROSpect II, and YKL-40 for discriminating fibrosis stages in chronic hepatitis C.
Mehta P; Ploutz-Snyder R; Nandi J; Rawlins SR; Sanderson SO; Levine RA
Am J Gastroenterol; 2008 Apr; 103(4):928-36. PubMed ID: 18371145
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.
Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE
Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.
Saitou Y; Shiraki K; Yamanaka Y; Yamaguchi Y; Kawakita T; Yamamoto N; Sugimoto K; Murata K; Nakano T
World J Gastroenterol; 2005 Jan; 11(4):476-81. PubMed ID: 15641129
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
Esmat G; Metwally M; Zalata KR; Gadalla S; Abdel-Hamid M; Abouzied A; Shaheen AA; El-Raziky M; Khatab H; El-Kafrawy S; Mikhail N; Magder LS; Afdhal NH; Strickland GT
J Hepatol; 2007 Apr; 46(4):620-7. PubMed ID: 17316875
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience.
Lee CK; Perez-Atayde AR; Mitchell PD; Raza R; Afdhal NH; Jonas MM
J Pediatr; 2013 Oct; 163(4):1058-64.e2. PubMed ID: 23759423
[TBL] [Abstract][Full Text] [Related]
9. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.
Rath T; Roderfeld M; Güler C; Wenzel C; Graf J; Beitinger F; Roeb E; Zachoval R
Scand J Gastroenterol; 2011 Nov; 46(11):1369-80. PubMed ID: 21905976
[TBL] [Abstract][Full Text] [Related]
10. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C.
Pungpapong S; Nunes DP; Krishna M; Nakhleh R; Chambers K; Ghabril M; Dickson RC; Hughes CB; Steers J; Nguyen JH; Keaveny AP
Liver Transpl; 2008 Sep; 14(9):1294-302. PubMed ID: 18756457
[TBL] [Abstract][Full Text] [Related]
11. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
12. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
14. Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value.
Zheng M; Cai WM; Zhao JK; Zhu SM; Liu RH
Acta Trop; 2005; 96(2-3):148-52. PubMed ID: 16188216
[TBL] [Abstract][Full Text] [Related]
15. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients.
Mansy SS; Nosseir MM; Zoheiry MA; Hassanein MH; Guda MF; Othman MM; AbuTalab H
Clin Chem Lab Med; 2014 Sep; 52(9):1319-28. PubMed ID: 24803609
[TBL] [Abstract][Full Text] [Related]
16. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
[TBL] [Abstract][Full Text] [Related]
17. Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Skiba E; Werpachowska I; Sobaniec-Łotowska ME; Kaczmarski M
Adv Med Sci; 2007; 52():120-4. PubMed ID: 18217402
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
El Guesiry D; Moez P; Hossam N; Kassem M
Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
[TBL] [Abstract][Full Text] [Related]
19. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
20. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
